Permethrin
FDA-approved product (lotion, topical), marketed as Elimite, Nix, Permethrin.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 2 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Parasitic infection
Indications ChEMBL records as approved, from FDA and DailyMed labels.
- WHO therapeutic group
- Pyrethrines, incl. synthetic compounds
- FDA pharmacologic class
- Pyrethroid FDA label ↗
- Anti-infective classification
- Classified as another kind of anti-infective (for example an antifungal, antiviral or antiparasitic medicine).WHO ATC P03AC04; WHO ATC P03AC54
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against MRSA and M. tuberculosis. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA41.0% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli31.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae13.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis48.4% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredAutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Permethrin with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Mefloquine HydrochlorideExisting use: Malaria, Plasmodium falciparum malaria, Plasmodium vivax malaria81.8% AI-predicted activityagainst M. tuberculosisLab records exist8 registered studies
- KetoconazoleExisting use: Adrenal gland disease, Blastomycosis, Cushing syndrome and 3 more81.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- LevoketoconazoleExisting use: Adrenal gland disease, Adrenal gland hyperfunction, Cushing syndrome81.2% AI-predicted activityagainst M. tuberculosis6 registered studies
- Fluphenazine DecanoateExisting use: Mental or behavioural disorder, Psychosis80.7% AI-predicted activityagainst M. tuberculosis4 registered studies
- Fluphenazine EnanthateExisting use: Mental or behavioural disorder, Psychosis80.7% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- NifurtimoxExisting use: American trypanosomiasis, Chagas disease, Leishmaniasis and 1 more78.4% AI-predicted activityagainst M. tuberculosis19 registered studies
- Fluphenazine HydrochlorideExisting use: Mental or behavioural disorder, Psychosis77.8% AI-predicted activityagainst M. tuberculosis5 registered studies
- NitazoxanideExisting use: Amebiasis, Diarrhea77.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- TopiramateExisting use: Epilepsy, Lennox-Gastaut syndrome, Migraine disorder and 1 more77.4% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- TrabectedinExisting use: Cancer, Dedifferentiated liposarcoma, Leiomyosarcoma and 7 more76.8% AI-predicted activityagainst M. tuberculosis50+ registered studies
- Chlorpromazine HydrochlorideExisting use: Conduct disorder, Mental or behavioural disorder, Nausea and vomiting and 3 more75.0% AI-predicted activityagainst M. tuberculosis33 registered studies
- ProchlorperazineExisting use: Anxiety disorder, Nausea and vomiting, Psychosis and 1 more74.1% AI-predicted activityagainst M. tuberculosis50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies
NCT02094716 · start 2014-04
Registered record
- Registry ID
- NCT02094716
- Conditions
- Scabies
- Interventions
- Permethrin Foam 4%; Permethrin Foam 5%; Vehicle Foam
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2014-04
- Completion
- 2014-12
- Enrolment
- 130
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionScabiesInterventionPermethrin Foam 4%; Permethrin Foam 5%; Vehicle FoamPhasePhase 2Registry statusCompletedInvestigation of Endemic and Emerging Diseases in Populations of Homeless Households in Marseille.
NCT02819128 · start 2014-01-25
Registered record
- Registry ID
- NCT02819128
- Conditions
- Endemic and Emerging Diseases in Populations of Homeless
- Interventions
- Swabs skin, pharyngeal, and blood sample; Collection of body lice
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2014-01-25
- Completion
- 2022-10-26
- Enrolment
- 722
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionEndemic and Emerging Diseases in Populations of HomelessInterventionSwabs skin, pharyngeal, and blood sample; Collection of body licePhaseNot applicableRegistry statusCompletedMindfulness Based Chronic Pain Management: A Pilot Study
NCT01886885 · start 2013-01
Registered record
- Registry ID
- NCT01886885
- Conditions
- Chronic Pain
- Interventions
- Mindfulness Based Chronic Pain Management Intervention
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2013-01
- Completion
- 2013-01
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic PainInterventionMindfulness Based Chronic Pain Management InterventionPhaseNot recordedRegistry statusCompletedRepellents as Added Control Measure to Long Lasting Insecticidal Nets
NCT01663831 · start 2012-05
Registered record
- Registry ID
- NCT01663831
- Conditions
- Malaria
- Interventions
- Mosquito topical repellent
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2012-05
- Completion
- 2013-12
- Enrolment
- 40,000
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMalariaInterventionMosquito topical repellentPhaseNot applicableRegistry statusCompletedInsecticidal School Uniforms for Dengue Prevention in Thailand
NCT01563640 · start 2012-03
Registered record
- Registry ID
- NCT01563640
- Conditions
- Dengue
- Interventions
- permethrin insecticide; washing
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2012-03
- Completion
- 2014-12
- Enrolment
- 1,825
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionDengueInterventionpermethrin insecticide; washingPhaseNot applicableRegistry statusTerminatedEfficacy and Safety of Licefreee Spray Against Nix 1% Permethrin
NCT01514513 · start 2011-08
Registered record
- Registry ID
- NCT01514513
- Conditions
- Pediculosis Capitis
- Interventions
- Licefreee Spray; 1% permethrin creme rinse
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2011-08
- Completion
- 2011-12
- Enrolment
- 42
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPediculosis CapitisInterventionLicefreee Spray; 1% permethrin creme rinsePhaseNot applicableRegistry statusCompletedEffectiveness of Permethrin Impregnated Underwear in Preventing Louse Proliferation in Infected Homeless
NCT01287663 · start 2011-01
Registered record
- Registry ID
- NCT01287663
- Conditions
- Body's Louses
- Interventions
- Permethrin impregnated; no Permethrin impregnated
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2011-01
- Completion
- 2012-05
- Enrolment
- 125
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBody's LousesInterventionPermethrin impregnated; no Permethrin impregnatedPhaseNot applicableRegistry statusTerminatedTick-borne Illness and Clothing Study
NCT01454414 · start 2010-10
Registered record
- Registry ID
- NCT01454414
- Conditions
- Tick Bites; Tick-borne Illness
- Interventions
- Permethrin Impregnated Uniforms
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2010-10
- Completion
- 2013-04
- Enrolment
- 159
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionTick Bites; Tick-borne IllnessInterventionPermethrin Impregnated UniformsPhaseNot applicableRegistry statusCompletedEfficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
NCT00927472 · start 2009-08
Registered record
- Registry ID
- NCT00927472
- Conditions
- Pediculosis
- Interventions
- Malathion gel 0.5%; Permethrin 1% rinse
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2009-08
- Completion
- 2010-06
- Enrolment
- 254
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPediculosisInterventionMalathion gel 0.5%; Permethrin 1% rinsePhasePhase 3Registry statusCompletedEfficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice
NCT00963508 · start 2009-08
Registered record
- Registry ID
- NCT00963508
- Conditions
- Pediculosis
- Interventions
- Malathion gel 0.5%; Permethrin 1% rinse (Nix Crème)
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2009-08
- Completion
- 2010-03
- Enrolment
- 403
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPediculosisInterventionMalathion gel 0.5%; Permethrin 1% rinse (Nix Crème)PhasePhase 3Registry statusCompletedPassive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes
NCT00958139 · start 2008-06
Registered record
- Registry ID
- NCT00958139
- Conditions
- Lyme Disease
- Interventions
- Permethrin; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Terminated
- Start
- 2008-06
- Completion
- 2008-10
- Enrolment
- 61
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionLyme DiseaseInterventionPermethrin; PlaceboPhasePhase 3Registry statusTerminatedSafety and Efficacy Study of NatrOVA Creme Rinse - 1% and NIX Creme Rinse in Subjects 6 Months or Older With Head Lice
NCT00545168 · start 2007-09
Registered record
- Registry ID
- NCT00545168
- Conditions
- Pediculus Capitis Infestation
- Interventions
- Spinosad; Spinosad; Permethrin 1%
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Completed
- Start
- 2007-09
- Completion
- 2008-05
- Enrolment
- 480
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPediculus Capitis InfestationInterventionSpinosad; Spinosad; Permethrin 1%PhasePhase 3Registry statusCompletedSafety and Efficacy Study to Compare a 4% Dimethicone Foam and Nix Cream Rinse (1% Permethrin) in the Control of Head Lice
NCT00672971 · start 2007-09
Registered record
- Registry ID
- NCT00672971
- Conditions
- Head Lice
- Interventions
- 4% dimethicone foam; 1% permethrin
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2007-09
- Completion
- 2007-11
- Enrolment
- 31
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHead LiceIntervention4% dimethicone foam; 1% permethrinPhaseNot applicableRegistry statusCompletedVeron Scabies Education and Eradication Program
NCT00604084 · start 2007-05
Registered record
- Registry ID
- NCT00604084
- Conditions
- Scabies
- Interventions
- Ivermectin; Permethrin 5% lotion
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2007-05
- Completion
- 2008-05
- Enrolment
- 1,057
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionScabiesInterventionIvermectin; Permethrin 5% lotionPhaseNot applicableRegistry statusCompletedA Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse
NCT00857935 · start 2007-03
Registered record
- Registry ID
- NCT00857935
- Conditions
- Pediculosis Capitis; Head Lice
- Interventions
- NatrOVA Creme Rinse - 1%; NIX Creme Rinse - 1% permethrin
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Completed
- Start
- 2007-03
- Completion
- 2007-04
- Enrolment
- 24
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPediculosis Capitis; Head LiceInterventionNatrOVA Creme Rinse - 1%; NIX Creme Rinse - 1% permethrinPhasePhase 2Registry statusCompleted